Single-cell multi-region dissection of AD-pathogen interactions for HSV-1 and CMV
HSV-1 和 CMV AD 病原体相互作用的单细胞多区域解剖
基本信息
- 批准号:10607814
- 负责人:
- 金额:$ 78.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAmyloid beta-ProteinAtlasesAutopsyBiological AssayBlood VesselsBrainBrain regionCOVID-19 pandemicCRISPR interferenceCell CommunicationCell SurvivalCellsCentral Nervous SystemCoculture TechniquesComplexComputing MethodologiesCytomegalovirusCytomegalovirus InfectionsDataData SetDementiaDevelopmentDiseaseDisease ProgressionDissectionEnvironmental ImpactEtiologyFamilyFoundationsGene Expression ProfileGene Expression ProfilingGene Expression RegulationGenesGeneticGenetic RiskGenetic TranscriptionGoalsHealthcareHerpesvirus 1HippocampusHumanImmuneImmune responseImpaired cognitionIndividualInfectionInterventionJointsLifeLinkMapsMediatingMemory LossMessenger RNAMicrogliaModelingMolecularMolecular Mechanisms of ActionMusNeurodegenerative DisordersNeuronsOrganoidsPathogenicityPathologicPathway interactionsPhenotypePost-Translational Protein ProcessingRegulatory ElementResearchResolutionResourcesRoleSamplingSeveritiesSimplexvirusTestingTranscription AlterationValidationVirusabeta depositionantimicrobial peptidebasebrain cellcare burdencausal variantcell typecerebrovasculardata integrationfrontal lobegenetic risk factorinduced pluripotent stem cellneuroinflammationnovel therapeuticspathogenpersonalized medicinepersonalized therapeuticprotein expressionrisk variantsexsingle nucleus RNA-sequencingsingle-cell RNA sequencingsmall molecule therapeutics
项目摘要
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that leads to dramatic effects on the affected
individuals and their families. While the characterization of the genetic contribution to AD and underlying
molecular mechanisms has advanced the understanding of the disease in recent years, studies have failed to
find definitive mechanisms that account for disease progression. The influence of pathogens on AD potentially
mediates an environmental impact on the established genetic contributions to AD. Here, we directly dissect the
contribution of pathogen-related effects down to the cell-type-specific molecular basis by systematic profiling,
computational integration, and experimental validation of the transcriptional signatures across individuals, brain
regions, and cell types. In Aim 1, we use scRNA-seq in human, mouse, and human iPSC brain organoid samples of
AD that are infected with Herpes Simplex Virus 1 or Cytomegalovirus (HSV-1/CMV) to generate millions of single-
cell (sc) level maps with the end goal of a transcriptional atlas. In Aim 2, we analyze the resulting datasets and
underlying molecular mechanisms, enabling us to discover and converge genes, pathways, cell types, and
brain regions to functional and causal mechanisms that drive pathogen-related alterations. In Aim 3, we use
our well-established iPSC model to test our predicted mechanisms with both high-throughput and cell-type
specific assays. The resulting datasets, computational predictions, and experimentally-supported mechanisms
will shed light on the pathogen-related influences on AD pathology and will help deepen our understanding of
the disease in general as we develop more personalized therapeutic approaches to treating AD.
抽象的
阿尔茨海默病 (AD) 是一种神经退行性疾病,会对受影响的患者造成巨大影响
个人及其家庭的遗传特征和潜在的 AD 贡献。
近年来,分子机制促进了对该疾病的了解,但研究未能
找到解释疾病进展的明确机制。
介导环境对 AD 的既定遗传贡献的影响。
通过系统分析将病原体相关影响深入到细胞类型特异性分子基础,
跨个体、大脑的转录特征的计算整合和实验验证
在目标 1 中,我们在人类、小鼠和人类 iPSC 大脑类器官样本中使用了 scRNA-seq。
感染单纯疱疹病毒 1 或巨细胞病毒 (HSV-1/CMV) 的 AD 会产生数百万个单
细胞(sc)水平图谱的最终目标是转录图谱。在目标 2 中,我们分析了生成的数据集并进行了分析。
潜在的分子机制,使我们能够发现和融合基因、途径、细胞类型和
在目标 3 中,我们使用了驱动病原体相关改变的大脑区域的功能和因果机制。
我们完善的 iPSC 模型可通过高通量和细胞类型测试我们预测的机制
特定的分析结果、计算预测和实验支持的机制。
将阐明病原体相关的 AD 病理学影响,并有助于加深我们对 AD 病理学的理解
随着我们开发出更个性化的治疗方法来治疗 AD,这种疾病总体上会得到改善。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manolis Kellis其他文献
Manolis Kellis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manolis Kellis', 18)}}的其他基金
Investigating cell-type specific convergence of APOE and ABCA7 lipid dysregulation in Alzheimer’s disease
研究阿尔茨海默病中 APOE 和 ABCA7 脂质失调的细胞类型特异性趋同
- 批准号:
10900993 - 财政年份:2023
- 资助金额:
$ 78.61万 - 项目类别:
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease
阿尔茨海默病性别特异性差异的单细胞表观基因组和转录解析
- 批准号:
10633255 - 财政年份:2021
- 资助金额:
$ 78.61万 - 项目类别:
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease
阿尔茨海默病性别特异性差异的单细胞表观基因组和转录解析
- 批准号:
10495202 - 财政年份:2021
- 资助金额:
$ 78.61万 - 项目类别:
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease
阿尔茨海默病性别特异性差异的单细胞表观基因组和转录解析
- 批准号:
10300867 - 财政年份:2021
- 资助金额:
$ 78.61万 - 项目类别:
Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease
阿尔茨海默病性别特异性差异的单细胞表观基因组和转录解析
- 批准号:
10633255 - 财政年份:2021
- 资助金额:
$ 78.61万 - 项目类别:
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease
阐明阿尔茨海默病神经精神症状的分子机制
- 批准号:
10177837 - 财政年份:2018
- 资助金额:
$ 78.61万 - 项目类别:
Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease
阐明阿尔茨海默病神经精神症状的分子机制
- 批准号:
10451516 - 财政年份:2018
- 资助金额:
$ 78.61万 - 项目类别:
Single-cell transcriptional and epigenomic dissection of Alzheimer's Disease and Related Dementias
阿尔茨海默病和相关痴呆症的单细胞转录和表观基因组解剖
- 批准号:
9791035 - 财政年份:2018
- 资助金额:
$ 78.61万 - 项目类别:
Single-cell transcriptional and epigenomic dissection of Alzheimer's Disease and Related Dementias
阿尔茨海默病和相关痴呆症的单细胞转录和表观基因组解剖
- 批准号:
10011923 - 财政年份:2018
- 资助金额:
$ 78.61万 - 项目类别:
Interpreting non-coding variants using epigenomics, regulatory models, & validation experiments
使用表观基因组学、调控模型解释非编码变异,
- 批准号:
9616350 - 财政年份:2017
- 资助金额:
$ 78.61万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 78.61万 - 项目类别:
Mitral Regurgitation Quantification Using Dual-venc 4D flow MRI and Deep learning
使用 Dual-venc 4D 流 MRI 和深度学习对二尖瓣反流进行量化
- 批准号:
10648495 - 财政年份:2023
- 资助金额:
$ 78.61万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 78.61万 - 项目类别:
Mechanisms Underpinning Afterload-Induced Atrial Fibrillation
后负荷诱发心房颤动的机制
- 批准号:
10679796 - 财政年份:2023
- 资助金额:
$ 78.61万 - 项目类别:
Mitochondrial dysfunction and tau pathology in Alzheimer's disease
阿尔茨海默病中的线粒体功能障碍和 tau 病理学
- 批准号:
10805120 - 财政年份:2023
- 资助金额:
$ 78.61万 - 项目类别: